Susan Rienow of Pfizer named Vice-President of the ABPI
The ABPI Board has confirmed that Susan Rienow, Country President of Pfizer, has been elected as Vice President of the Association of the British Pharmaceutical Industry (ABPI).
The pharmaceutical industry can play a crucial role in generating the economic growth the UK desperately needs at this point, as well as helping the NHS to recover from the pandemic. Susan Rienow, ABPI Vice-President
As Vice-President, she will support the President Pinder Sahota, General Manager and Corporate Vice President of Novo Nordisk UK in delivering his priorities. These are improving access to medicines, delivering economic growth and helping to find solutions to big societal challenges such as climate change, AMR, and inequalities.
At Pfizer, Susan leads the organisation to bring the power of innovation, data and technology together to transform healthcare and improve outcomes for patients. She previously led Pfizer UK’s Vaccines business unit during the COVID-19 pandemic.
Commenting on her appointment, Susan said:
“The pharmaceutical industry can play a crucial role in generating the economic growth the UK desperately needs at this point, as well as helping the NHS to recover from the pandemic.
“I look forward to working with the President to make sure that lessons from the pandemic are learned and innovative medicines and vaccines reach the people who need them.”
- Health and Access to Medicines
Last modified: 20 September 2023
Last reviewed: 20 September 2023